The estimated Net Worth of Global Master Fund Lp Logos is at least $12.7 Million dollars as of 9 November 2020. Global Logos owns over 476,667 units of Miragen Therapeutics Inc stock worth over $12,655,500 and over the last 4 years Global sold MGEN stock worth over $0.
Sign up
Global Logos MGEN stock SEC Form 4 insiders trading
Global has made over 1 trades of the Miragen Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Global bought 476,667 units of MGEN stock worth $2,268,935 on 9 November 2020.
The largest trade Global's ever made was buying 476,667 units of Miragen Therapeutics Inc stock on 9 November 2020 worth over $2,268,935. On average, Global trades about 476,667 units every 0 days since 2020. As of 9 November 2020 Global still owns at least 550,000 units of Miragen Therapeutics Inc stock.
You can see the complete history of Global Logos stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Global Logos's mailing address?
Global's mailing address filed with the SEC is C/O OGIER GLOBAL (CAYMAN) LIMITED, 89 NEXUS WAY, CAMANA BAY, E9, KY1-9009.
Insiders trading at Miragen Therapeutics Inc
Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over $636,110 worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth $5,368,137 . The most active insiders traders include Bennett S Lebow, Bruce Booth, and Paul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of $2,345,685. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth $2,268,935.
What does Miragen Therapeutics Inc's logo look like?
Complete history of Global Logos stock trades at Miragen Therapeutics Inc
Miragen Therapeutics Inc executives and stock owners
Miragen Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Diana Escolar,
Chief Medical Officer -
Jason Leverone,
Principal Financial Officer, Principal Accounting Officer, Treasurer, Secretary -
Jeffrey Hatfield,
Independent Chairman of the Board -
Joseph Turner,
Independent Director -
Arlene Morris,
Independent Director -
Christopher Bowden,
Independent Director -
Tomas Kiselak,
Director -
Peter Harwin,
Director -
Lee Rauch,
Chief Executive Officer, Director -
Jonathan Violin,
President, Chief Operating Officer -
Bruce Booth,
Director -
Kyle Lefkoff,
Director -
Paul D Rubin,
EVP, Research & Development -
Adam Scott Levy,
Chief Business Officer -
Thomas E. Hughes,
Director -
Bennett S Lebow,
Director -
Global Master Fund Lp Logos,
10% owner -
John W Creecy,
Director -
Kevin Koch,
Director -
Funds Management Llc Fairmo...,
-
William Stuart Marshall,